- Home
- BNC vs BIOA Comparison
BNC vs BIOA Comparison
Compare BNC & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNC | BIOA |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 287.3M | 255.6M |
| IPO Year | 2010 | 2024 |
Fundamental Metrics
Financial Performance| Metric | BNC | BIOA |
|---|---|---|
| Price | $5.34 | $5.11 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $32.56 |
| AVG Volume (30 Days) | ★ 835.4K | 824.7K |
| Earning Date | 09-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 159.72 | 66.21 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,581,968.00 | $8,995,000.00 |
| Revenue This Year | $27.15 | N/A |
| Revenue Next Year | $6.70 | $97.72 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.89 | N/A |
| 52 Week Low | $1.84 | $4.81 |
| 52 Week High | $7.99 | $25.96 |
Technical Indicators
Market Signals| Indicator | BNC | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 52.72 | 28.22 |
| Support Level | $2.15 | $4.81 |
| Resistance Level | $5.58 | $8.53 |
| Average True Range (ATR) | 0.25 | 0.37 |
| MACD | -0.06 | 0.10 |
| Stochastic Oscillator | 55.24 | 15.82 |
Price Performance
Historical ComparisonAbout BNC CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.